Accueil
Programme
Programme en un coup d'oeil
Programme détaillé
Liste des intervenants
Inscriptions
S'inscrire
Retrait des badges
Soumission de résumé
ART
Informations pratiques
Plan d'accès au congrès
Horaires du congrès
Hébergement
Transport
Crédits Formation et Conventions de formation
Partenaires
Page groupe
Replay CFA 2024
Contact
Mon compte
Votre badge
ART
Tuesday, April 15, 2025
•
ART
•
9:00 AM
>
5:00 PM
•
ART
•
Salle 352 B
9:00 AM
•
INT165
•
Introduction
9:15 AM
•
INT166
•
Session 1: New players in allergic diseases
9:15 AM
•
INT167
•
From IL-33 to TL1A: role of alarmin cytokines in the initiation of allergic airway inflammation
>
J-P.
Jean-Philippe
GIRARD
(Toulouse)
10:00 AM
•
INT168
•
IL-20 cytokines: Friend or foes in chronic airway diseases
>
M.
Muriel
PICHAVANT
(Lille)
10:35 AM
•
INT169
•
Does the Gut Microbiome mediate the impact of Lifestyle on metabolic Phenotypes?
>
K.
Karine
CLEMENT
(Paris)
11:10 AM
•
INT170
•
Coffee break
11:30 AM
•
INT171
•
Session 2: New insights into the roles of basophils
11:30 AM
•
INT172
•
Basophils as Gatekeepers: Amplifying Asthma Through IL-33-Driven Th2 Infiltration
>
M.
Martijn
SCHUIJS
(Gent)
12:05 PM
•
INT173
•
Basophils in the control of humoral autoimmunity
>
N.
Nicolas
CHARLES
(Paris)
12:40 PM
•
INT174
•
Lunch
1:40 PM
•
INT175
•
Session 3: Immune mechanisms of allergic diseases
1:40 PM
•
INT176
•
Peripheral neuroimmune interactions in allergic inflammation
>
N.
Nicolas
GAUDENZIO
(Toulouse)
2:15 PM
•
INT177
•
Mast cell-mediated immunosurveillance of the blood stream
>
A.
Axel
ROERS
(Heidelberg)
2:50 PM
•
INT178
•
Billions of neutrophils: Exploring the multiple facets of neutrophils in lung homeostasis and allergic diseases
>
C.
Coraline
RADERMECKER
(Liège)
3:25 PM
•
INT179
•
Coffee break
3:45 PM
•
INT180
•
Session 4: Novel targets in allergic diseases
3:45 PM
•
INT181
•
CCL2 chemokine follows a complex bitemporal secretion pattern for local attraction during IgE-mediated mast cell activation
>
E.
Eduardo
MONTERO
(Paris)
4:10 PM
•
INT182
•
Artificial intelligence and biomarker-driven approaches in developing novel therapeutics for allergic diseases
>
M.
Mohamed
SHAMJI
(London)
4:55 PM
•
INT183
•
Concluding remarks
>
V.
Virginie
DOYEN
(Yvoir)
,
F.
Frédéric
BERARD
(Lyon)
Copyright © 2025 Margaux Orange.
All rights reserved. /
Politique de confidentialité
Copyright © key4events - All rights reserved